FIELD: medicine, immunopharmacology, pharmacy, biochemistry. SUBSTANCE: method involves determination of the NADPH-oxidase reaction rate in white cell homogenates or in fraction of polymorphonuclear leukocytes of peripheral blood before and after addition of substances to be study to sample. Immunomodulating activity is detected by increase of the NADPH-oxidase reaction rate. Specific property of immunomodulating agents is a direct activation of NADPH-oxidase in homogenates of nonactivated white cells of peripheral blood and peritoneal macrophages. The property of potential immunomodulating agents to activate NADPH-oxidase in homogenates of "resting" white cells of peripheral blood and macrophages by their direct addition to homogenates in vitro is proved on example of immunomodulating agents of different structure, for example, as pyrimidine derivative (uracil), polypetide preparation Tactivin from cattle thymus gland, coneflower herb dry extract where sesquiterpene lactones are the acting component. Specificity of claimed method is proved on the basis of absence of activating effect of dragonhead herb dry extract showing antioxidant properties. Invention ensures to enhance sensitivity and economy of detection of immunomodulating activity in vitro. EFFECT: improved method of detection. 4 ex
Title | Year | Author | Number |
---|---|---|---|
AGENT SHOWING EFFECT WITH RESPECT TO INFECTIOUS AGENTS | 1994 |
|
RU2092177C1 |
IMMUNOSTIMULATING AGENT ESTIFEN AND METHOD OF ITS PREPARING | 1998 |
|
RU2137490C1 |
METHOD OF DETERMINING ANTI-OXIDANT ACTIVITY OF ESSENTIAL OIL OF VEGETABLE ORIGIN in vitro | 2013 |
|
RU2526125C1 |
AGENT HAVING IMMUNOMODULATORY ACTIVITY, AND A METHOD FOR PRODUCTION THEREOF | 2019 |
|
RU2710270C1 |
CURATIVE-PROPHYLAXIS AGENT FOR TREATMENT OF PROSTATITIS, URETHRITIS AND OTHER INFLAMMATORY ILLNESSES OF UROGENITAL SYSTEM | 1996 |
|
RU2098119C1 |
ADAPTOGENIC AGENT | 2003 |
|
RU2240799C1 |
METHOD FOR DETECTING ANTITOXIC PROPERTY IN BIOLOGICALLY ACTIVE SUBSTANCES | 2006 |
|
RU2316597C1 |
DRUG FOR TREATMENT OF PATIENTS WITH VIRAL DISEASE | 1994 |
|
RU2118163C1 |
METHOD OF SANGUIRITRINE PREPARING | 1999 |
|
RU2167668C2 |
DRUG POSSESSING INTERFERON-INDUCING AND IMMUNOMODULATING (IMMUNOSTIMULATING) ACTIVITY | 1987 |
|
RU2033157C1 |
Authors
Dates
2002-12-10—Published
2000-04-14—Filed